Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591529202> ?p ?o ?g. }
- W2591529202 abstract "It is now widely accepted that insulin resistance and compensatory hyperinsulinemia are associated to increased cancer incidence and mortality. Moreover, cancer development and progression as well as cancer resistance to traditional anticancer therapies are often linked to a deregulation/overactivation of the insulin-like growth factor (IGF) axis, which involves the autocrine/paracrine production of IGFs (IGF-I and IGF-II) and overexpression of their cognate receptors [IGF-I receptor, IGF-insulin receptor (IR), and IR]. Recently, new drugs targeting various IGF axis components have been developed. However, these drugs have several limitations including the occurrence of insulin resistance and compensatory hyperinsulinemia, which, in turn, may affect cancer cell growth and survival. Therefore, new therapeutic approaches are needed. In this regard, the pleiotropic effects of peroxisome proliferator activated receptor (PPAR)-γ agonists may have promising applications in cancer prevention and therapy. Indeed, activation of PPAR-γ by thiazolidinediones (TZDs) or other agonists may inhibit cell growth and proliferation by lowering circulating insulin and affecting key pathways of the Insulin/IGF axis, such as PI3K/mTOR, MAPK, and GSK3-β/Wnt/β-catenin cascades, which regulate cancer cell survival, cell reprogramming, and differentiation. In light of these evidences, TZDs and other PPAR-γ agonists may be exploited as potential preventive and therapeutic agents in tumors addicted to the activation of IGF axis or occurring in hyperinsulinemic patients. Unfortunately, clinical trials using PPAR-γ agonists as antineoplastic agents have reached conflicting results, possibly because they have not selected tumors with overactivated insulin/IGF-I axis or occurring in hyperinsulinemic patients. In conclusion, the use of PPAR-γ agonists in combined therapies of IGF-driven malignancies looks promising but requires future developments." @default.
- W2591529202 created "2017-03-03" @default.
- W2591529202 creator A5034366324 @default.
- W2591529202 creator A5050819403 @default.
- W2591529202 creator A5055143240 @default.
- W2591529202 creator A5065399264 @default.
- W2591529202 creator A5070485233 @default.
- W2591529202 creator A5089369408 @default.
- W2591529202 date "2017-02-22" @default.
- W2591529202 modified "2023-10-16" @default.
- W2591529202 title "PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis" @default.
- W2591529202 cites W1495133409 @default.
- W2591529202 cites W1511151098 @default.
- W2591529202 cites W1523693806 @default.
- W2591529202 cites W1532932203 @default.
- W2591529202 cites W1552323930 @default.
- W2591529202 cites W1560977824 @default.
- W2591529202 cites W1573681132 @default.
- W2591529202 cites W1586597239 @default.
- W2591529202 cites W1722193072 @default.
- W2591529202 cites W1871669466 @default.
- W2591529202 cites W1899346463 @default.
- W2591529202 cites W1955442983 @default.
- W2591529202 cites W1963664301 @default.
- W2591529202 cites W1963951927 @default.
- W2591529202 cites W1964286374 @default.
- W2591529202 cites W1964402722 @default.
- W2591529202 cites W1964410726 @default.
- W2591529202 cites W1967910935 @default.
- W2591529202 cites W1968444524 @default.
- W2591529202 cites W1969176613 @default.
- W2591529202 cites W1969525074 @default.
- W2591529202 cites W1970342864 @default.
- W2591529202 cites W1970637701 @default.
- W2591529202 cites W1970879266 @default.
- W2591529202 cites W1971343583 @default.
- W2591529202 cites W1972499055 @default.
- W2591529202 cites W1973048609 @default.
- W2591529202 cites W1973474920 @default.
- W2591529202 cites W1974658675 @default.
- W2591529202 cites W1976766119 @default.
- W2591529202 cites W1977666051 @default.
- W2591529202 cites W1978125779 @default.
- W2591529202 cites W1978281808 @default.
- W2591529202 cites W1979069886 @default.
- W2591529202 cites W1980115178 @default.
- W2591529202 cites W1981336087 @default.
- W2591529202 cites W1981946836 @default.
- W2591529202 cites W1982060240 @default.
- W2591529202 cites W1982209166 @default.
- W2591529202 cites W1983868597 @default.
- W2591529202 cites W1988966548 @default.
- W2591529202 cites W1994049242 @default.
- W2591529202 cites W1994482949 @default.
- W2591529202 cites W1994833377 @default.
- W2591529202 cites W1997146974 @default.
- W2591529202 cites W2000093938 @default.
- W2591529202 cites W2001480066 @default.
- W2591529202 cites W2001740185 @default.
- W2591529202 cites W2003420643 @default.
- W2591529202 cites W2003537519 @default.
- W2591529202 cites W2003699768 @default.
- W2591529202 cites W2003960793 @default.
- W2591529202 cites W2004473236 @default.
- W2591529202 cites W2004880100 @default.
- W2591529202 cites W2006340844 @default.
- W2591529202 cites W2006851815 @default.
- W2591529202 cites W2008717167 @default.
- W2591529202 cites W2010052382 @default.
- W2591529202 cites W2010390458 @default.
- W2591529202 cites W2012260744 @default.
- W2591529202 cites W2013531958 @default.
- W2591529202 cites W2014205300 @default.
- W2591529202 cites W2015663542 @default.
- W2591529202 cites W2016298087 @default.
- W2591529202 cites W2020552177 @default.
- W2591529202 cites W2021075371 @default.
- W2591529202 cites W2025192214 @default.
- W2591529202 cites W2025308819 @default.
- W2591529202 cites W2025865695 @default.
- W2591529202 cites W2030656376 @default.
- W2591529202 cites W2030693139 @default.
- W2591529202 cites W2031694725 @default.
- W2591529202 cites W2033166543 @default.
- W2591529202 cites W2036361556 @default.
- W2591529202 cites W2037002277 @default.
- W2591529202 cites W2037073171 @default.
- W2591529202 cites W2038012681 @default.
- W2591529202 cites W2041237929 @default.
- W2591529202 cites W2041319301 @default.
- W2591529202 cites W2042159031 @default.
- W2591529202 cites W2043129312 @default.
- W2591529202 cites W2046403598 @default.
- W2591529202 cites W2047591801 @default.
- W2591529202 cites W2048030072 @default.
- W2591529202 cites W2054154194 @default.
- W2591529202 cites W2054556235 @default.
- W2591529202 cites W2055413953 @default.
- W2591529202 cites W2055561557 @default.
- W2591529202 cites W2056550511 @default.